Rackliffe Philip has filed 17 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 24598 shares of GE HealthCare Technologies Inc. ($GEHC) on March 02, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | A | Employee Stock Option (right to buy) | 24598 | $0.00 | 24,598.0000 | 458,000,000 | 9999.99% | 0.01% |
| March 2, 2026 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | A | Common Stock, par value $0.01 per share | 9356 | $0.00 | 26,729.0000 | 458,000,000 | 53.85% | 0.00% |
| Feb. 12, 2026 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 1174 | $79.20 | 17,373.0000 | 458,000,000 | 6.33% | 0.00% |
| Feb. 12, 2026 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | A | Common Stock, par value $0.01 per share | 3154 | $0.00 | 18,547.0000 | 458,000,000 | 20.49% | 0.00% |
| Feb. 1, 2026 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 189 | $78.97 | 15,393.0000 | 458,000,000 | 1.21% | 0.00% |
| Sept. 1, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 165 | $73.73 | 17,308.0000 | 459,000,000 | 0.94% | 0.00% |
| Sept. 1, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 134 | $73.73 | 17,174.0000 | 459,000,000 | 0.77% | 0.00% |
| Sept. 1, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 204 | $73.73 | 16,970.0000 | 459,000,000 | 1.19% | 0.00% |
| Sept. 1, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 1388 | $73.73 | 15,582.0000 | 459,000,000 | 8.18% | 0.00% |
| March 3, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | A | Common Stock, par value $0.01 per share | 4916 | $0.00 | 17,473.0000 | 459,000,000 | 39.15% | 0.00% |
| March 3, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | A | Employee Stock Option (right to buy) | 14058 | $0.00 | 14,058.0000 | 459,000,000 | 9999.99% | 0.00% |
| Feb. 1, 2025 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | F | Common Stock, par value $0.01 per share | 158 | $88.30 | 12,557.0000 | 459,000,000 | 1.24% | 0.00% |
| Nov. 5, 2024 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, AVS | S | Common Stock, par value $0.01 per share | 900 | $87.63 | 12,715.0000 | 459,000,000 | 6.61% | 0.00% |
| Sept. 1, 2024 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, Ultrasound & IGT | F | Common Stock, par value $0.01 per share | 1388 | $84.82 | 13,780.0000 | 458,000,000 | 9.15% | 0.00% |
| Sept. 1, 2024 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, Ultrasound & IGT | F | Common Stock, par value $0.01 per share | 165 | $84.82 | 13,615.0000 | 458,000,000 | 1.20% | 0.00% |
| Aug. 15, 2024 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, Ultrasound & IGT | A | Common Stock, par value $0.01 per share | 2051 | $0.00 | 15,168.0000 | 458,000,000 | 15.64% | 0.00% |
| Aug. 15, 2024 | GE HealthCare Technologies Inc. | $GEHC | Rackliffe Philip | CEO, Ultrasound & IGT | A | Employee Stock Option (right to buy) | 6203 | $0.00 | 6,203.0000 | 458,000,000 | 9999.99% | 0.00% |